Retinoid [EPC]

Retinoid [EPC] was reported 247485 times

Drugs of the Retinoid [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 CHEMICAL BURN OF SKIN 1815 0.7154
1 ACNE FULMINANS 126 0.6429
2 SKIN FRAGILITY 1516 0.6223
3 SKIN BURNING SENSATION 42234 0.5890
4 SKIN IRRITATION 26743 0.5832
5 NO ADVERSE EFFECT 989 0.5470
6 INFLAMMATORY BOWEL DISEASE 5285 0.5396
7 ACNE 40651 0.5356
8 ACNE CYSTIC 1540 0.5108
9 DILATED PORES 45 0.4945
10 GASTROINTESTINAL INJURY 1261 0.4684
11 PAIN OF SKIN 12542 0.4653
12 SEBORRHOEA 1624 0.4417
13 RETINOIC ACID SYNDROME 74 0.4302
14 PREGNANCY TEST FALSE POSITIVE 192 0.4120
15 ACUTE PROMYELOCYTIC LEUKAEMIA DIFFERENTIATION SYNDROME 82 0.3942
16 SENSITIVE SKIN 2859 0.3871
17 ACNE PUSTULAR 311 0.3793
18 SKIN HYPOPIGMENTATION 646 0.3650
19 DRY SKIN 48399 0.3622
20 NEUROLOGIC NEGLECT SYNDROME 198 0.3561
21 SKIN HYPERPIGMENTATION 2879 0.3347
22 SKIN DISCOMFORT 885 0.3278
23 DIFFERENTIATION SYNDROME 240 0.3270
24 PROCTITIS ULCERATIVE 192 0.3184
25 EPIPHYSES PREMATURE FUSION 96 0.3168
26 XEROSIS 376 0.3037
27 NASAL VESTIBULITIS 30 0.3000
28 SELECTIVE ABORTION 52 0.2971
29 NO ADVERSE REACTION 42 0.2877
30 SKIN SWELLING 2343 0.2697
31 SKIN EXFOLIATION 22369 0.2649
32 CAROTID ARTERY THROMBOSIS 201 0.2367
33 NO ADVERSE DRUG EFFECT 157 0.2312
34 CHEMICAL BURN 256 0.2220
35 SKIN TIGHTNESS 945 0.2007
36 LIP DRY 1818 0.2000
37 ILEITIS 75 0.1948
38 ERYTHEMA 39634 0.1926
39 RASH PAPULAR 4237 0.1888
40 UNINTENDED PREGNANCY 1941 0.1856
41 SAPHO SYNDROME 43 0.1741
42 CROHN'S DISEASE 1152 0.1679
43 TRANSMISSION OF DRUG VIA SEMEN 79 0.1639
44 ADJUSTMENT DISORDER 211 0.1623
45 ABORTION INDUCED 1467 0.1556
46 PITYRIASIS RUBRA PILARIS 35 0.1471
47 DRUG EXPOSURE BEFORE PREGNANCY 149 0.1469
48 CHAPPED LIPS 590 0.1358
49 OVERLAP SYNDROME 92 0.1314
50 RECTAL POLYP 129 0.1307
51 PREGNANCY TEST POSITIVE 51 0.1298
52 PERIRECTAL ABSCESS 140 0.1262
53 EYELID EXFOLIATION 95 0.1203
54 PERIORBITAL IRRITATION 40 0.1170
55 RASH MACULAR 4022 0.1149
56 SKIN FISSURES 2169 0.1109
57 DERMATITIS 2284 0.1089
58 SCAR 1866 0.1089
59 PREGNANCY 2177 0.1086
60 SKIN WARM 617 0.1059
61 IRRITABLE BOWEL SYNDROME 2207 0.1028
62 SKIN INJURY 341 0.1027
63 SACROILIITIS 193 0.1022
64 SCAB 1122 0.0983
65 POST INFLAMMATORY PIGMENTATION CHANGE 44 0.0971
66 CHEILITIS 523 0.0966
67 POUCHITIS 82 0.0952
68 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 16730 0.0927
69 RECTAL FISSURE 55 0.0873
70 BLOOD TRIGLYCERIDES INCREASED 1529 0.0864
71 COLITIS ULCERATIVE 3851 0.0861
72 PYOGENIC GRANULOMA 40 0.0858
73 EYELID IRRITATION 215 0.0856
74 HYPOCHOLESTEROLAEMIA 30 0.0850
75 PREGNANCY OF PARTNER 60 0.0846
76 BENIGN INTRACRANIAL HYPERTENSION 106 0.0844
77 SKIN HAEMORRHAGE 1231 0.0830
78 PERSONALITY DISORDER 213 0.0812
79 COLONIC POLYP 133 0.0805
80 SKIN TEXTURE ABNORMAL 76 0.0793
81 EYELID SKIN DRYNESS 93 0.0767
82 ERYTHRODERMIC PSORIASIS 63 0.0765
83 PRODUCT ADMINISTRATION INTERRUPTED 590 0.0751
84 NIGHT BLINDNESS 120 0.0749
85 SKIN REACTION 1020 0.0723
86 PROCTITIS 200 0.0713
87 MEIBOMIAN GLAND DYSFUNCTION 32 0.0706
88 ROSACEA 327 0.0701
89 ANAL STENOSIS 37 0.0694
90 ANAL FISSURE 372 0.0693
91 UNDERDOSE 5041 0.0690
92 SUNBURN 509 0.0682
93 MULTI-ORGAN DISORDER 134 0.0681
94 EAR MALFORMATION 31 0.0670
95 SKIN WRINKLING 180 0.0662
96 OVERDOSE 13370 0.0619
97 ANAL FISTULA 328 0.0614
98 PERIORAL DERMATITIS 38 0.0598
99 SKIN DISCOLOURATION 2752 0.0598
100 COLON INJURY 34 0.0591
101 MYCOSIS FUNGOIDES 48 0.0583
102 JOINT ANKYLOSIS 33 0.0581
103 SKIN EROSION 178 0.0552
104 CUTANEOUS T-CELL LYMPHOMA 69 0.0548
105 RASH ERYTHEMATOUS 2591 0.0541
106 NORMAL NEWBORN 292 0.0537
107 VULVAL DISORDER 35 0.0530
108 LARGE INTESTINE POLYP 366 0.0528
109 LIP HAEMORRHAGE 65 0.0509
110 SKIN INDURATION 104 0.0501
111 BLEPHAROSPASM 315 0.0500
112 LIVE BIRTH 418 0.0499
113 EXPOSURE VIA BODY FLUID 39 0.0496
114 INFECTIOUS MONONUCLEOSIS 111 0.0495
115 INTERNAL INJURY 32 0.0491
116 MOOD ALTERED 1336 0.0489
117 APPLICATION SITE DRYNESS 164 0.0483
118 LIP EXFOLIATION 64 0.0481
119 HYPERSENSITIVITY 8850 0.0476
120 DERMAL CYST 114 0.0464
121 FACET JOINT SYNDROME 149 0.0457
122 LUPUS VULGARIS 55 0.0437
123 DRUG INEFFECTIVE 56630 0.0429
124 PERIPHERAL VENOUS DISEASE 172 0.0421
125 PRODUCT DISPENSING ISSUE 180 0.0420
126 EYELID RASH 41 0.0419
127 LIPIDS INCREASED 84 0.0416
128 GENITAL ULCERATION 32 0.0416
129 SWELLING FACE 2686 0.0412
130 ONYCHOMADESIS 173 0.0412
131 PREGNANCY ON ORAL CONTRACEPTIVE 106 0.0404
132 NASAL DRYNESS 250 0.0399
133 ILEAL ULCER 40 0.0395
134 RASH 17229 0.0395
135 CHOLANGITIS SCLEROSING 81 0.0394
136 DRUG EXPOSURE DURING PREGNANCY 1322 0.0388
137 EDUCATIONAL PROBLEM 63 0.0379
138 PREGNANCY ON CONTRACEPTIVE 55 0.0376
139 LIP ERYTHEMA 30 0.0375
140 INFUSION SITE REACTION 112 0.0375
141 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 268 0.0374
142 RHEUMATIC FEVER 166 0.0372
143 ACUTE PROMYELOCYTIC LEUKAEMIA 38 0.0370
144 PUSTULE 87 0.0367
145 APPLICATION SITE EXFOLIATION 147 0.0357
146 EYE SWELLING 1320 0.0354
147 EXPOSURE DURING PREGNANCY 2200 0.0354
148 PRURITUS 13133 0.0341
149 BONE CYST 32 0.0341
150 IDIOPATHIC INTRACRANIAL HYPERTENSION 75 0.0333
151 BLISTER 1832 0.0326
152 CHRONIC FATIGUE SYNDROME 45 0.0323
153 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 2244 0.0315
154 GANGRENE 188 0.0312
155 AFFECT LABILITY 298 0.0309
156 DEPRESSIVE SYMPTOM 109 0.0309
157 SWELLING OF EYELID 194 0.0309
158 ECTOPIC PREGNANCY 95 0.0309
159 FURUNCLE 242 0.0305
160 PUSTULAR PSORIASIS 104 0.0303
161 SELF-INJURIOUS IDEATION 125 0.0298
162 DISLOCATION OF VERTEBRA 67 0.0293
163 HYPERTRIGLYCERIDAEMIA 171 0.0292
164 SENSORY LOSS 229 0.0284
165 DEPRESSION 6283 0.0276
166 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 196 0.0273
167 PAPULE 192 0.0272
168 PERIORBITAL SWELLING 152 0.0269
169 IMPETIGO 40 0.0268
170 RECTAL ABSCESS 45 0.0268
171 BREAST CANCER STAGE III 171 0.0264
172 ANAL ABSCESS 142 0.0263
173 ABORTION 76 0.0260
174 HIDRADENITIS 237 0.0260
175 SKIN ATROPHY 147 0.0255
176 SKIN INFECTION 285 0.0254
177 SUICIDAL IDEATION 2258 0.0246
178 HEMIPLEGIA 205 0.0246
179 SMALL INTESTINAL OBSTRUCTION 303 0.0246
180 SKIN ABRASION 116 0.0245
181 GASTROINTESTINAL OEDEMA 43 0.0243
182 LEUKAEMIA RECURRENT 41 0.0242
183 INTESTINAL OBSTRUCTION 914 0.0242
184 ARTERIAL OCCLUSIVE DISEASE 190 0.0241
185 APHTHOUS STOMATITIS 55 0.0238
186 ERYTHEMA OF EYELID 128 0.0236
187 FOLLICULITIS 247 0.0235
188 HAEMORRHOIDS 454 0.0233
189 URTICARIA 3897 0.0232
190 RETINITIS 40 0.0231
191 MUCOSAL DRYNESS 46 0.0228
192 THERAPEUTIC PRODUCT EFFECT DECREASED 1018 0.0227
193 MILIARIA 39 0.0227
194 EMPYEMA 45 0.0226
195 TREATMENT NONCOMPLIANCE 1218 0.0222
196 VULVOVAGINAL CANDIDIASIS 30 0.0222
197 DEEP VEIN THROMBOSIS POSTOPERATIVE 44 0.0220
198 BLOOD CHOLESTEROL INCREASED 1022 0.0219
199 SEBORRHOEIC DERMATITIS 36 0.0218
200 HYPERCHOLESTEROLAEMIA 210 0.0217
201 PYODERMA GANGRENOSUM 77 0.0214
202 ILEAL STENOSIS 38 0.0214
203 COLITIS 809 0.0213
204 EYELID PAIN 43 0.0211
205 CONDITION AGGRAVATED 6434 0.0211
206 RASH PUSTULAR 152 0.0209
207 SKIN PLAQUE 176 0.0208
208 INGROWING NAIL 49 0.0207
209 RECTAL HAEMORRHAGE 891 0.0207
210 DUODENAL ULCER PERFORATION 154 0.0207
211 MOTOR DYSFUNCTION 211 0.0207
212 SKIN PAPILLOMA 82 0.0204
213 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 42 0.0203
214 PRODUCT USE IN UNAPPROVED INDICATION 4972 0.0200
215 MOOD SWINGS 637 0.0200
216 ABORTION SPONTANEOUS 799 0.0199
217 ALANINE AMINOTRANSFERASE ABNORMAL 42 0.0199
218 DERMATITIS EXFOLIATIVE GENERALISED 69 0.0198
219 BONE EROSION 70 0.0198
220 ADVERSE DRUG REACTION 1775 0.0197
221 INTRACRANIAL PRESSURE INCREASED 110 0.0197
222 THERAPY CESSATION 1003 0.0195
223 ABDOMINAL ABSCESS 86 0.0194
224 MUSCLE INJURY 154 0.0186
225 SINUS CONGESTION 251 0.0186
226 DEVICE RELATED SEPSIS 37 0.0184
227 DRY EYE 913 0.0183
228 BILIARY DYSKINESIA 30 0.0177
229 MATERNAL EXPOSURE BEFORE PREGNANCY 120 0.0175
230 BACK INJURY 191 0.0175
231 SCRATCH 183 0.0173
232 MUSCLE SPASTICITY 213 0.0173
233 PARONYCHIA 76 0.0173
234 APPLICATION SITE DISCOLOURATION 70 0.0172
235 TASTE DISORDER 348 0.0171
236 ADVERSE REACTION 226 0.0170
237 BIPOLAR DISORDER 185 0.0170
238 SKIN MASS 113 0.0169
239 NAIL DISORDER 148 0.0169
240 AFFECTIVE DISORDER 132 0.0168
241 ECZEMA 874 0.0167
242 MELANOCYTIC NAEVUS 73 0.0166
243 OSTEOLYSIS 34 0.0166
244 BURSITIS 201 0.0166
245 HIGH DENSITY LIPOPROTEIN DECREASED 55 0.0165
246 COORDINATION ABNORMAL 223 0.0160
247 ERYTHEMA NODOSUM 56 0.0159
248 EYE IRRITATION 905 0.0157
249 GROWTH RETARDATION 46 0.0156
250 MAJOR DEPRESSION 114 0.0156
251 PHOTOSENSITIVITY REACTION 254 0.0154
252 INJURY 1080 0.0153
253 RESPIRATORY TRACT CONGESTION 243 0.0153
254 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 35 0.0152
255 SKIN ULCER 391 0.0151
256 PAPILLOEDEMA 68 0.0150
257 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 40 0.0150
258 SOCIAL AVOIDANT BEHAVIOUR 87 0.0150
259 SYNOVITIS 270 0.0150
260 PRODUCT USE ISSUE 2808 0.0149
261 EYELIDS PRURITUS 46 0.0147
262 IRON DEFICIENCY ANAEMIA 136 0.0147
263 HAND DEFORMITY 193 0.0147
264 WOUND INFECTION 161 0.0147
265 ACTINIC KERATOSIS 38 0.0146
266 SKIN HYPERTROPHY 41 0.0146
267 CYST 180 0.0145
268 SWOLLEN JOINT COUNT INCREASED 46 0.0144
269 SKIN LESION 395 0.0144
270 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 33 0.0142
271 FACIAL PAIN 126 0.0141
272 EPISTAXIS 1054 0.0141
273 PIGMENTATION DISORDER 86 0.0139
274 BLEPHARITIS 55 0.0137
275 PERICARDITIS 228 0.0136
276 WOUND SECRETION 53 0.0135
277 PEMPHIGUS 169 0.0135
278 PSORIATIC ARTHROPATHY 542 0.0133
279 HELICOBACTER INFECTION 137 0.0133
280 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 729 0.0133
281 SINUS DISORDER 260 0.0131
282 DERMATITIS CONTACT 148 0.0130
283 LIP PAIN 37 0.0129
284 STAPHYLOCOCCAL BACTERAEMIA 56 0.0129
285 HYPERKERATOSIS 71 0.0129
286 ANAL HAEMORRHAGE 36 0.0128
287 POLYP 84 0.0128
288 SELF INJURIOUS BEHAVIOUR 39 0.0128
289 LIVER FUNCTION TEST INCREASED 273 0.0127
290 MACULE 35 0.0126
291 MYOPIA 30 0.0126
292 HEMIPARESIS 213 0.0126
293 SNEEZING 282 0.0126
294 HORDEOLUM 54 0.0125
295 OSTEOPENIA 188 0.0124
296 VULVOVAGINAL DRYNESS 40 0.0124
297 C-REACTIVE PROTEIN ABNORMAL 79 0.0123
298 MATERNAL EXPOSURE DURING PREGNANCY 1094 0.0123
299 EATING DISORDER 261 0.0122
300 DYSLIPIDAEMIA 62 0.0122
301 JOINT RANGE OF MOTION DECREASED 160 0.0119
302 LOW DENSITY LIPOPROTEIN INCREASED 92 0.0119
303 PSORIASIS 1550 0.0119
304 THERMAL BURN 84 0.0118
305 RASH VESICULAR 57 0.0118
306 PEPTIC ULCER 39 0.0117
307 HEPATIC FIBROSIS 40 0.0116
308 SQUAMOUS CELL CARCINOMA OF SKIN 69 0.0114
309 PRODUCT DISPENSING ERROR 248 0.0114
310 LIP BLISTER 31 0.0114
311 CHOLECYSTITIS CHRONIC 75 0.0112
312 DECREASED INTEREST 66 0.0112
313 MENTAL DISORDER 483 0.0111
314 EPILEPSY 339 0.0111
315 PRODUCT PHYSICAL CONSISTENCY ISSUE 60 0.0108
316 OCULAR HYPERAEMIA 510 0.0107
317 OBESITY 169 0.0106
318 HEPATIC ENZYME INCREASED 722 0.0106
319 WOUND 296 0.0106
320 NEGATIVE THOUGHTS 31 0.0106
321 APPLICATION SITE ERYTHEMA 275 0.0105
322 ORAL HERPES 204 0.0104
323 APPLICATION SITE SWELLING 52 0.0104
324 FISTULA 117 0.0104
325 APPLICATION SITE PAIN 227 0.0103
326 DEPRESSED MOOD 543 0.0103
327 CONGENITAL ANOMALY 79 0.0102
328 RED BLOOD CELL SEDIMENTATION RATE INCREASED 112 0.0101
329 LOSS OF LIBIDO 91 0.0101
330 DUODENITIS 31 0.0101
331 ERECTILE DYSFUNCTION 259 0.0101
332 SUICIDAL BEHAVIOUR 41 0.0098
333 SUBCUTANEOUS ABSCESS 47 0.0098
334 EXOSTOSIS 89 0.0097
335 APPLICATION SITE IRRITATION 121 0.0097
336 STAPHYLOCOCCAL SEPSIS 48 0.0097
337 GASTROINTESTINAL DISORDER 868 0.0097
338 PANIC ATTACK 352 0.0096
339 LACRIMATION INCREASED 291 0.0096
340 ANGER 324 0.0096
341 DERMATITIS ACNEIFORM 58 0.0095
342 BLOOD CHOLESTEROL ABNORMAL 44 0.0095
343 SUICIDE ATTEMPT 574 0.0095
344 SKIN DISORDER 314 0.0094
345 OTITIS MEDIA 31 0.0094
346 PERSONALITY CHANGE 87 0.0094
347 DRUG DISPENSING ERROR 143 0.0093
348 EYELID OEDEMA 108 0.0093
349 ANXIETY DISORDER 31 0.0093
350 TENDERNESS 96 0.0092
351 TONGUE ULCERATION 31 0.0092
352 AUTOIMMUNE DISORDER 89 0.0091
353 LIP SWELLING 302 0.0091
354 FIBROMYALGIA 220 0.0090
355 LABORATORY TEST ABNORMAL 267 0.0090
356 RHEUMATOID FACTOR POSITIVE 52 0.0090
357 ANXIETY 2558 0.0090
358 DEPRESSION SUICIDAL 31 0.0089
359 KLEBSIELLA INFECTION 45 0.0089
360 TEARFULNESS 38 0.0088
361 SQUAMOUS CELL CARCINOMA 83 0.0088
362 ADVERSE EVENT 812 0.0088
363 CONTRAINDICATED PRODUCT ADMINISTERED 266 0.0088
364 OBSESSIVE-COMPULSIVE DISORDER 70 0.0087
365 ENTEROCOCCAL INFECTION 42 0.0087
366 PARAESTHESIA 1361 0.0086
367 TYPE 1 DIABETES MELLITUS 52 0.0086
368 LIGAMENT RUPTURE 38 0.0086
369 VASCULAR DEVICE INFECTION 39 0.0086
370 DRUG INTOLERANCE 828 0.0086
371 RHINITIS ALLERGIC 38 0.0085
372 LIVER FUNCTION TEST ABNORMAL 248 0.0085
373 DIVERTICULUM 60 0.0084
374 OSTEOARTHRITIS 352 0.0083
375 DERMATITIS ALLERGIC 103 0.0082
376 GRIP STRENGTH DECREASED 72 0.0082
377 APHASIA 247 0.0082
378 COELIAC DISEASE 80 0.0081
379 SKIN ODOUR ABNORMAL 32 0.0081
380 RASH PRURITIC 440 0.0081
381 ARTHRITIS 636 0.0081
382 GLOSSODYNIA 181 0.0081
383 TONSILLITIS 42 0.0080
384 VISUAL DISTURBANCE 46 0.0080
385 DRUG PRESCRIBING ERROR 154 0.0080
386 MATERNAL EXPOSURE TIMING UNSPECIFIED 30 0.0080
387 ONYCHOMYCOSIS 35 0.0080
388 CYSTITIS 254 0.0080
389 INCORRECT DOSAGE ADMINISTERED 39 0.0080
390 LARGE INTESTINE PERFORATION 55 0.0079
391 ANGINA PECTORIS 226 0.0079
392 DIVERTICULITIS 216 0.0078
393 PANIC DISORDER 30 0.0077
394 APPLICATION SITE BURN 38 0.0077
395 PREGNANCY WITH CONTRACEPTIVE DEVICE 69 0.0077
396 TREATMENT FAILURE 635 0.0077
397 EAR PAIN 149 0.0077
398 EMOTIONAL DISTRESS 924 0.0076
399 ACUTE MYELOID LEUKAEMIA 118 0.0076
400 PRODUCT PRESCRIBING ERROR 180 0.0075
401 CRYING 274 0.0075
402 GASTROOESOPHAGEAL REFLUX DISEASE 605 0.0075
403 NIGHT SWEATS 242 0.0075
404 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 534 0.0075
405 PSYCHIATRIC SYMPTOM 55 0.0074
406 REBOUND EFFECT 84 0.0074
407 FINGER DEFORMITY 36 0.0074
408 ASPARTATE AMINOTRANSFERASE INCREASED 392 0.0074
409 GAIT INABILITY 246 0.0074
410 POOR QUALITY PRODUCT ADMINISTERED 77 0.0073
411 APPENDICITIS 68 0.0073
412 IMPAIRED HEALING 239 0.0073
413 SOCIAL PROBLEM 30 0.0072
414 HEPATIC ENZYME ABNORMAL 36 0.0072
415 PRE-EXISTING CONDITION IMPROVED 45 0.0072
416 POLYARTHRITIS 38 0.0072
417 PRODUCT PRESCRIBING ISSUE 157 0.0072
418 HYPERTRANSAMINASAEMIA 50 0.0072
419 COLITIS MICROSCOPIC 34 0.0072
420 HYPERCALCAEMIA 88 0.0071
421 PRODUCT DOSE OMISSION ISSUE 2086 0.0071
422 INFLAMMATION 366 0.0071
423 C-REACTIVE PROTEIN INCREASED 258 0.0071
424 MIGRAINE 673 0.0070
425 HYSTERECTOMY 61 0.0070
426 INTERVERTEBRAL DISC DEGENERATION 65 0.0070
427 EYE PRURITUS 236 0.0070
428 POST-TRAUMATIC STRESS DISORDER 47 0.0070
429 BREAST CANCER STAGE II 58 0.0070
430 ENDOMETRIOSIS 33 0.0069
431 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 42 0.0069
432 PREMATURE LABOUR 39 0.0069
433 PHARYNGITIS 85 0.0068
434 DERMATITIS EXFOLIATIVE 34 0.0068
435 APPETITE DISORDER 45 0.0068
436 SYSTEMIC LUPUS ERYTHEMATOSUS 239 0.0067
437 SKIN LACERATION 73 0.0067
438 FREQUENT BOWEL MOVEMENTS 181 0.0067
439 PRODUCT LABEL CONFUSION 39 0.0067
440 SEXUAL DYSFUNCTION 78 0.0066
441 DYSARTHRIA 250 0.0066
442 LIVER INJURY 163 0.0066
443 HERPES SIMPLEX 43 0.0066
444 OESOPHAGITIS 72 0.0066
445 ENTERITIS 42 0.0066
446 ALANINE AMINOTRANSFERASE INCREASED 401 0.0065
447 TYPE 2 DIABETES MELLITUS 219 0.0065
448 STREPTOCOCCAL INFECTION 36 0.0065
449 PHOTOPHOBIA 121 0.0064
450 ARTHRALGIA 2658 0.0064
451 STAPHYLOCOCCAL INFECTION 210 0.0064
452 CONJUNCTIVITIS 118 0.0064
453 HAIR GROWTH ABNORMAL 44 0.0064
454 EMOTIONAL DISORDER 196 0.0064
455 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 41 0.0063
456 NECK PAIN 352 0.0063
457 HYPERLIPIDAEMIA 75 0.0063
458 MYALGIA 1064 0.0063
459 APATHY 91 0.0062
460 PROCTALGIA 40 0.0062
461 HAEMATOCHEZIA 343 0.0062
462 PHARYNGOLARYNGEAL PAIN 33 0.0062
463 OVARIAN CYST 62 0.0062
464 MATERNAL DRUGS AFFECTING FOETUS 47 0.0061
465 ARTHROPATHY 339 0.0061
466 DIARRHOEA HAEMORRHAGIC 57 0.0061
467 IRRITABILITY 362 0.0060
468 DYSPHORIA 30 0.0059
469 AGGRESSION 296 0.0059
470 ILEUS 73 0.0059
471 MYOSITIS 52 0.0058
472 RHINORRHOEA 373 0.0058
473 NODULE 75 0.0057
474 MYELODYSPLASTIC SYNDROME 83 0.0057
475 INTENTIONAL SELF-INJURY 115 0.0057
476 BLOOD ALKALINE PHOSPHATASE INCREASED 141 0.0057
477 TRANSAMINASES INCREASED 126 0.0057
478 VAGINAL HAEMORRHAGE 245 0.0056
479 ABSCESS 90 0.0056
480 FEELING HOT 341 0.0056
481 HEPATIC CIRRHOSIS 104 0.0055
482 SINUSITIS 566 0.0055
483 PHARYNGITIS STREPTOCOCCAL 59 0.0054
484 ALOPECIA 1069 0.0054
485 TENDONITIS 84 0.0054
486 VENTRICULAR SEPTAL DEFECT 31 0.0054
487 THERAPY PARTIAL RESPONDER 84 0.0054
488 UPPER RESPIRATORY TRACT INFECTION 248 0.0054
489 SECRETION DISCHARGE 67 0.0053
490 SCOLIOSIS 33 0.0053
491 NEUTROPENIC SEPSIS 38 0.0053
492 JOINT DISLOCATION 56 0.0053
493 APHTHOUS ULCER 41 0.0053
494 GASTRITIS 139 0.0053
495 BACK PAIN 1227 0.0053
496 NEPHROLITHIASIS 241 0.0052
497 ONYCHOCLASIS 36 0.0052
498 DRY MOUTH 424 0.0052
499 JOINT EFFUSION 36 0.0052
500 BASAL CELL CARCINOMA 81 0.0052
501 ABDOMINAL PAIN 1207 0.0052
502 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 175 0.0052
503 PSYCHOTIC DISORDER 153 0.0052
504 CONCUSSION 40 0.0052
505 GASTROENTERITIS 75 0.0051
506 PLATELET COUNT INCREASED 67 0.0051
507 ANHEDONIA 135 0.0051
508 HYPERAESTHESIA 42 0.0051
509 EYE PAIN 287 0.0051
510 EYE INFECTION 57 0.0050
511 CANDIDA INFECTION 85 0.0050
512 WALKING AID USER 33 0.0050
513 THINKING ABNORMAL 93 0.0050
514 LUPUS-LIKE SYNDROME 45 0.0050
515 TINNITUS 226 0.0049
516 DEVICE RELATED INFECTION 75 0.0049
517 ORAL CANDIDIASIS 64 0.0049
518 HEADACHE 3022 0.0048
519 CLOSTRIDIUM DIFFICILE COLITIS 51 0.0048
520 SWELLING 450 0.0048
521 IMPAIRED QUALITY OF LIFE 69 0.0048
522 INTENTIONAL UNDERDOSE 35 0.0048
523 MUSCULOSKELETAL PAIN 251 0.0048
524 GALLBLADDER DISORDER 85 0.0048
525 RHEUMATOID ARTHRITIS 540 0.0048
526 CAESAREAN SECTION 55 0.0047
527 DYSPHAGIA 448 0.0047
528 APPLICATION SITE PRURITUS 107 0.0047
529 HALLUCINATION, AUDITORY 74 0.0047
530 DISTURBANCE IN ATTENTION 251 0.0046
531 PRODUCT QUALITY ISSUE 632 0.0046
532 CATARACT 277 0.0046
533 THERAPY NON-RESPONDER 208 0.0046
534 BLOOD TEST ABNORMAL 65 0.0046
535 BURNING SENSATION 324 0.0046
536 BLOOD CREATINE PHOSPHOKINASE INCREASED 133 0.0046
537 LOCALISED INFECTION 111 0.0046
538 LEUKOCYTOSIS 83 0.0046
539 HEPATIC STEATOSIS 85 0.0046
540 SLEEP APNOEA SYNDROME 87 0.0046
541 PARANOIA 78 0.0045
542 VISION BLURRED 620 0.0045
543 BRAIN OEDEMA 57 0.0045
544 FUNGAL INFECTION 150 0.0045
545 ROAD TRAFFIC ACCIDENT 188 0.0045
546 INCORRECT PRODUCT STORAGE 59 0.0045
547 MUSCULAR WEAKNESS 510 0.0045
548 HIATUS HERNIA 58 0.0045
549 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 76 0.0045
550 BREAST MASS 30 0.0045
551 ABNORMAL BEHAVIOUR 177 0.0045
552 GASTROINTESTINAL INFECTION 40 0.0045
553 DRUG-INDUCED LIVER INJURY 140 0.0045
554 SURGERY 261 0.0044
555 VAGINAL DISCHARGE 45 0.0044
556 HYPOTHYROIDISM 141 0.0044
557 EYE INFLAMMATION 42 0.0044
558 UTERINE LEIOMYOMA 32 0.0044
559 INTENTIONAL PRODUCT USE ISSUE 383 0.0044
560 SLEEP DISORDER 307 0.0043
561 MYASTHENIA GRAVIS 35 0.0043
562 QUALITY OF LIFE DECREASED 58 0.0043
563 MADAROSIS 50 0.0043
564 THERAPEUTIC RESPONSE DECREASED 261 0.0043
565 THERAPY INTERRUPTED 307 0.0043
566 BLOOD ALBUMIN DECREASED 34 0.0043
567 MUCOSAL INFLAMMATION 111 0.0042
568 VITAMIN D DECREASED 36 0.0042
569 SECOND PRIMARY MALIGNANCY 35 0.0042
570 PRODUCT ODOUR ABNORMAL 44 0.0042
571 STOMATITIS 254 0.0042
572 APPLICATION SITE RASH 57 0.0041
573 POOR QUALITY SLEEP 89 0.0041
574 MOUTH ULCERATION 87 0.0041
575 NASOPHARYNGITIS 761 0.0041
576 DEEP VEIN THROMBOSIS 267 0.0041
577 INFLUENZA 457 0.0041
578 LOWER RESPIRATORY TRACT INFECTION 184 0.0040
579 LYMPHADENOPATHY 143 0.0040
580 OSTEOPOROSIS 166 0.0040
581 VASCULITIS 47 0.0040
582 ABDOMINAL DISCOMFORT 673 0.0040
583 DYSMENORRHOEA 53 0.0040
584 LUNG DISORDER 195 0.0040
585 GASTRIC ULCER 75 0.0039
586 LIGAMENT SPRAIN 39 0.0039
587 DRY THROAT 40 0.0039
588 VITAMIN D DEFICIENCY 38 0.0039
589 INFLUENZA LIKE ILLNESS 319 0.0039
590 WHEEZING 229 0.0039
591 HYPOALBUMINAEMIA 30 0.0039
592 CELLULITIS 193 0.0038
593 SCIATICA 61 0.0038
594 HAIR TEXTURE ABNORMAL 51 0.0038
595 SENSATION OF FOREIGN BODY 32 0.0038
596 ABDOMINAL PAIN UPPER 781 0.0038
597 DISCOMFORT 231 0.0038
598 HEAVY MENSTRUAL BLEEDING 34 0.0038
599 THERAPY CHANGE 37 0.0038
600 CONTUSION 360 0.0037
601 HYPOAESTHESIA 558 0.0037
602 VIRAL INFECTION 124 0.0037
603 EYE DISORDER 122 0.0037
604 LOWER LIMB FRACTURE 71 0.0037
605 PHARYNGEAL SWELLING 36 0.0037
606 FACE OEDEMA 62 0.0037
607 HEPATITIS 94 0.0037
608 AMENORRHOEA 64 0.0036
609 SPINAL OSTEOARTHRITIS 32 0.0036
610 BLOOD IRON DECREASED 43 0.0036
611 CHEST DISCOMFORT 371 0.0036
612 MENSTRUAL DISORDER 30 0.0036
613 ACCIDENT 43 0.0036
614 PULMONARY FIBROSIS 69 0.0036
615 DEAFNESS 94 0.0036
616 HYPERSOMNIA 103 0.0036
617 MALNUTRITION 40 0.0036
618 ANOREXIA 46 0.0036
619 EXPIRED PRODUCT ADMINISTERED 118 0.0035
620 SEASONAL ALLERGY 50 0.0035
621 PALPITATIONS 412 0.0035
622 IMPAIRED WORK ABILITY 75 0.0035
623 SENSORY DISTURBANCE 56 0.0035
624 RASH MACULO-PAPULAR 77 0.0035
625 BACTERAEMIA 41 0.0035
626 CHOLECYSTITIS 41 0.0034
627 ANAEMIA 654 0.0034
628 PRODUCT USE COMPLAINT 54 0.0034
629 RENAL DISORDER 159 0.0034
630 BLOOD BILIRUBIN INCREASED 92 0.0034
631 LYMPHOPENIA 48 0.0034
632 INTESTINAL PERFORATION 38 0.0034
633 MEMORY IMPAIRMENT 465 0.0034
634 PANCREATITIS 178 0.0034
635 LIVER DISORDER 149 0.0034
636 VITREOUS FLOATERS 33 0.0034
637 ANKYLOSING SPONDYLITIS 44 0.0033
638 HAEMATOCRIT DECREASED 66 0.0033
639 JOINT INJURY 71 0.0033
640 VISUAL IMPAIRMENT 411 0.0033
641 MUSCULOSKELETAL STIFFNESS 290 0.0033
642 EAR INFECTION 88 0.0033
643 COMPLETED SUICIDE 275 0.0033
644 LEUKAEMIA 31 0.0033
645 PAIN 2000 0.0033
646 CLOSTRIDIUM DIFFICILE INFECTION 71 0.0032
647 BODY TEMPERATURE DECREASED 32 0.0032
648 DIPLOPIA 84 0.0032
649 HEPATOTOXICITY 72 0.0032
650 ORAL PAIN 72 0.0032
651 WHITE BLOOD CELL COUNT INCREASED 123 0.0032
652 PULMONARY EMBOLISM 304 0.0032
653 MITRAL VALVE INCOMPETENCE 36 0.0032
654 MENSTRUATION IRREGULAR 85 0.0032
655 UVEITIS 43 0.0032
656 FRACTURE 60 0.0032
657 SPINAL DISORDER 30 0.0032
658 ORAL DISCOMFORT 44 0.0032
659 OEDEMA 171 0.0031
660 INFECTION 456 0.0031
661 JOINT SWELLING 380 0.0031
662 MYOCARDITIS 36 0.0031
663 INFUSION RELATED REACTION 207 0.0031
664 DERMATITIS ATOPIC 164 0.0031
665 DRUG EFFECT LESS THAN EXPECTED 46 0.0031
666 PRESCRIBED OVERDOSE 60 0.0031
667 COLON CANCER 46 0.0031
668 BRONCHITIS 228 0.0031
669 CHOLELITHIASIS 101 0.0031
670 FOETAL EXPOSURE DURING PREGNANCY 250 0.0031
671 CONFUSIONAL STATE 497 0.0031
672 BONE DISORDER 56 0.0031
673 HEAD DISCOMFORT 54 0.0030
674 JOINT STIFFNESS 80 0.0030
675 MOBILITY DECREASED 219 0.0030
676 GASTROENTERITIS VIRAL 55 0.0030
677 MYDRIASIS 39 0.0030
678 OROPHARYNGEAL PAIN 281 0.0030
679 THERAPEUTIC RESPONSE UNEXPECTED 136 0.0030
680 UNEVALUABLE EVENT 229 0.0030
681 IMMUNODEFICIENCY 45 0.0030
682 ULCER 48 0.0030
683 TEMPERATURE INTOLERANCE 31 0.0030
684 GENERAL PHYSICAL HEALTH DETERIORATION 347 0.0030
685 PYREXIA 1032 0.0030
686 ILL-DEFINED DISORDER 181 0.0030
687 CHOLECYSTECTOMY 34 0.0030
688 ADRENAL INSUFFICIENCY 36 0.0030
689 EYELID PTOSIS 30 0.0029
690 IMPAIRED GASTRIC EMPTYING 40 0.0029
691 DYSURIA 108 0.0029
692 PRODUCT PHYSICAL ISSUE 59 0.0029
693 PALLOR 79 0.0029
694 FEBRILE NEUTROPENIA 192 0.0029
695 VENTRICULAR EXTRASYSTOLES 30 0.0029
696 FOOT DEFORMITY 32 0.0029
697 INTENTIONAL DOSE OMISSION 82 0.0029
698 HAEMORRHAGE INTRACRANIAL 43 0.0029
699 BRAIN FOG 45 0.0029
700 FEAR 77 0.0029
701 DYSPEPSIA 281 0.0029
702 VOMITING 1342 0.0029
703 SCHIZOPHRENIA 34 0.0028
704 MANIA 46 0.0028
705 BLOOD PRESSURE INCREASED 427 0.0028
706 THYROID DISORDER 43 0.0028
707 PROTEINURIA 53 0.0028
708 INSOMNIA 742 0.0028
709 MUSCULOSKELETAL DISORDER 53 0.0028
710 PERIPHERAL SWELLING 428 0.0028
711 RESPIRATORY DISORDER 83 0.0028
712 DRUG ERUPTION 49 0.0028
713 MENTAL IMPAIRMENT 67 0.0028
714 HEPATIC CYTOLYSIS 35 0.0027
715 DISEASE RECURRENCE 130 0.0027
716 HAIR COLOUR CHANGES 34 0.0027
717 MUSCULOSKELETAL DISCOMFORT 47 0.0027
718 CONVULSION 156 0.0027
719 GASTROINTESTINAL PAIN 30 0.0027
720 MASS 38 0.0027
721 DISSEMINATED INTRAVASCULAR COAGULATION 38 0.0027
722 HYPERTENSION 571 0.0027
723 ILLNESS 277 0.0027
724 THIRST 48 0.0027
725 BACTERIAL INFECTION 50 0.0027
726 OFF LABEL USE 2339 0.0027
727 BONE PAIN 156 0.0027
728 DELUSION 41 0.0026
729 HERNIA 51 0.0026
730 CHEST PAIN 487 0.0026
731 PNEUMONIA 845 0.0026
732 INTERVERTEBRAL DISC PROTRUSION 57 0.0026
733 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 76 0.0026
734 NO ADVERSE EVENT 469 0.0026
735 LYMPHOMA 40 0.0026
736 NASAL CONGESTION 151 0.0026
737 HEPATITIS C 31 0.0026
738 PERICARDIAL EFFUSION 59 0.0025
739 ACUTE RESPIRATORY FAILURE 49 0.0025
740 SINUS TACHYCARDIA 36 0.0025
741 GAMMA-GLUTAMYLTRANSFERASE INCREASED 56 0.0025
742 PRODUCT ADMINISTRATION ERROR 51 0.0025
743 BACK DISORDER 41 0.0025
744 ANKLE FRACTURE 39 0.0025
745 KIDNEY INFECTION 49 0.0025
746 NAUSEA 1962 0.0025
747 AMNESIA 161 0.0025
748 RESTLESS LEGS SYNDROME 45 0.0025
749 VISUAL ACUITY REDUCED 82 0.0025
750 HAEMATURIA 84 0.0025
751 ELECTROCARDIOGRAM QT PROLONGED 88 0.0024
752 THROAT TIGHTNESS 66 0.0024
753 WEIGHT DECREASED 678 0.0024
754 FATIGUE 1887 0.0024
755 GASTRIC DISORDER 83 0.0024
756 PANCREATITIS ACUTE 54 0.0024
757 ECONOMIC PROBLEM 36 0.0024
758 TOOTHACHE 43 0.0024
759 ACUTE RESPIRATORY DISTRESS SYNDROME 42 0.0024
760 OSTEOMYELITIS 43 0.0024
761 HIP ARTHROPLASTY 36 0.0023
762 MUSCLE SPASMS 428 0.0023
763 SKIN CANCER 50 0.0023
764 PAIN IN EXTREMITY 684 0.0023
765 FOOT FRACTURE 44 0.0023
766 HALLUCINATION, VISUAL 49 0.0023
767 LIMB INJURY 63 0.0023
768 HYPERHIDROSIS 297 0.0023
769 MENORRHAGIA 45 0.0023
770 INSURANCE ISSUE 35 0.0023
771 PARAESTHESIA ORAL 33 0.0023
772 IMMUNE SYSTEM DISORDER 30 0.0023
773 DISABILITY 45 0.0023
774 AGITATION 167 0.0023
775 ASTHMA 257 0.0023
776 PNEUMOTHORAX 36 0.0023
777 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 108 0.0022
778 COUGH 625 0.0022
779 WEIGHT INCREASED 499 0.0022
780 RESPIRATORY TRACT INFECTION 58 0.0022
781 HAEMORRHAGE 231 0.0022
782 PRESCRIBED UNDERDOSE 44 0.0022
783 PRODUCT AVAILABILITY ISSUE 50 0.0022
784 DELIRIUM 76 0.0022
785 DIARRHOEA 1406 0.0022
786 CHROMATURIA 49 0.0022
787 CEREBROVASCULAR ACCIDENT 367 0.0022
788 MALAISE 948 0.0022
789 PELVIC PAIN 39 0.0021
790 ASTHENIA 804 0.0021
791 LEUKOPENIA 106 0.0021
792 COAGULOPATHY 35 0.0021
793 SEPSIS 234 0.0021
794 THROAT IRRITATION 94 0.0021
795 NERVOUS SYSTEM DISORDER 65 0.0021
796 ABDOMINAL DISTENSION 217 0.0021
797 MUSCULOSKELETAL CHEST PAIN 32 0.0021
798 BLOOD URINE PRESENT 39 0.0021
799 DRUG INTERACTION 324 0.0020
800 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 35 0.0020
801 THROMBOCYTOPENIA 228 0.0020
802 CARDIOMYOPATHY 30 0.0020
803 SYNCOPE 203 0.0020
804 FEELING ABNORMAL 485 0.0020
805 PANCYTOPENIA 113 0.0020
806 INTENTIONAL PRODUCT MISUSE 177 0.0020
807 BLOOD LACTATE DEHYDROGENASE INCREASED 32 0.0020
808 PHARYNGEAL OEDEMA 31 0.0020
809 PRODUCT SUBSTITUTION ISSUE 116 0.0020
810 PULMONARY MASS 30 0.0020
811 OSTEONECROSIS 66 0.0020
812 LETHARGY 115 0.0020
813 METRORRHAGIA 34 0.0020
814 DIZZINESS 990 0.0020
815 SEPTIC SHOCK 86 0.0020
816 NIGHTMARE 68 0.0020
817 BODY TEMPERATURE INCREASED 40 0.0020
818 GOUT 35 0.0019
819 CHOKING 38 0.0019
820 KNEE ARTHROPLASTY 41 0.0019
821 WHITE BLOOD CELL COUNT DECREASED 210 0.0019
822 JAUNDICE 52 0.0019
823 HALLUCINATION 145 0.0019
824 BLOOD POTASSIUM INCREASED 31 0.0019
825 LIMB DISCOMFORT 59 0.0019
826 DECREASED APPETITE 440 0.0019
827 NEURALGIA 46 0.0019
828 BLINDNESS 77 0.0019
829 OEDEMA PERIPHERAL 229 0.0019
830 MUSCLE TWITCHING 43 0.0019
831 PREMATURE BABY 56 0.0019
832 RESPIRATORY DISTRESS 51 0.0018
833 MULTIPLE ORGAN DYSFUNCTION SYNDROME 52 0.0018
834 LOCAL SWELLING 32 0.0018
835 DRUG RESISTANCE 47 0.0018
836 URINARY TRACT INFECTION 311 0.0018
837 DIABETES MELLITUS 138 0.0018
838 PLEURAL EFFUSION 110 0.0018
839 DISEASE PROGRESSION 213 0.0018
840 ANAPHYLACTIC REACTION 99 0.0018
841 ABDOMINAL PAIN LOWER 45 0.0018
842 HEPATIC FUNCTION ABNORMAL 66 0.0018
843 HERPES ZOSTER 101 0.0018
844 UPPER LIMB FRACTURE 35 0.0018
845 TACHYCARDIA 156 0.0018
846 POLLAKIURIA 73 0.0017
847 ANGIOEDEMA 77 0.0017
848 DEHYDRATION 232 0.0017
849 MULTI-ORGAN FAILURE 30 0.0017
850 ACTIVITIES OF DAILY LIVING IMPAIRED 34 0.0017
851 HYPOGLYCAEMIA 83 0.0017
852 PRURITUS GENERALISED 37 0.0017
853 ENCEPHALOPATHY 42 0.0017
854 MEDICATION ERROR 95 0.0017
855 HEAD INJURY 54 0.0017
856 NEUTROPENIA 232 0.0017
857 LYMPHOCYTE COUNT DECREASED 30 0.0017
858 PRODUCT DOSE OMISSION 110 0.0017
859 FLUSHING 170 0.0017
860 CONSTIPATION 364 0.0017
861 STEVENS-JOHNSON SYNDROME 37 0.0017
862 TOOTH DISORDER 37 0.0017
863 GLAUCOMA 32 0.0017
864 RHABDOMYOLYSIS 69 0.0017
865 COVID-19 289 0.0016
866 GAIT DISTURBANCE 315 0.0016
867 NEUTROPHIL COUNT DECREASED 67 0.0016
868 BLOOD CREATININE INCREASED 107 0.0016
869 CHILLS 192 0.0016
870 CHRONIC KIDNEY DISEASE 124 0.0016
871 BONE MARROW FAILURE 33 0.0016
872 DRUG EFFECT DECREASED 87 0.0016
873 DYSPNOEA 909 0.0016
874 FALL 534 0.0016
875 RIB FRACTURE 33 0.0016
876 HEART RATE DECREASED 56 0.0016
877 HEART RATE IRREGULAR 36 0.0016
878 HAEMATEMESIS 40 0.0016
879 DYSSTASIA 46 0.0016
880 ACUTE MYOCARDIAL INFARCTION 46 0.0016
881 ANAPHYLACTIC SHOCK 40 0.0015
882 HAEMOPTYSIS 43 0.0015
883 HEART RATE INCREASED 151 0.0015
884 FAECES DISCOLOURED 33 0.0015
885 HOT FLUSH 114 0.0015
886 BLOOD PRESSURE DECREASED 100 0.0015
887 HYPOXIA 53 0.0015
888 VERTIGO 91 0.0015
889 ABNORMAL DREAMS 41 0.0015
890 FLATULENCE 84 0.0015
891 CEREBRAL INFARCTION 36 0.0015
892 THERAPEUTIC RESPONSE SHORTENED 48 0.0014
893 INCORRECT DOSE ADMINISTERED 330 0.0014
894 PRODUCTIVE COUGH 69 0.0014
895 HYPOACUSIS 62 0.0014
896 BONE DENSITY DECREASED 45 0.0014
897 COGNITIVE DISORDER 67 0.0014
898 HAEMOGLOBIN DECREASED 145 0.0014
899 SWOLLEN TONGUE 44 0.0014
900 RENAL FAILURE 186 0.0014
901 NERVOUSNESS 73 0.0014
902 NEOPLASM MALIGNANT 93 0.0014
903 LOSS OF CONSCIOUSNESS 178 0.0014
904 URINARY INCONTINENCE 41 0.0014
905 CARDIOVASCULAR DISORDER 35 0.0014
906 PAIN IN JAW 39 0.0014
907 HYPERGLYCAEMIA 50 0.0014
908 SOMNOLENCE 276 0.0014
909 DYSPHONIA 80 0.0014
910 PULMONARY OEDEMA 61 0.0014
911 GASTROINTESTINAL HAEMORRHAGE 113 0.0014
912 HYPOKALAEMIA 62 0.0013
913 PRODUCT DOSE OMISSION IN ERROR 38 0.0013
914 ABASIA 33 0.0013
915 MENTAL STATUS CHANGES 37 0.0013
916 RENAL FAILURE ACUTE 56 0.0013
917 RASH GENERALISED 34 0.0013
918 FLUID RETENTION 66 0.0013
919 URINARY RETENTION 43 0.0013
920 PRESYNCOPE 31 0.0013
921 DEVICE DISLOCATION 55 0.0013
922 DEVICE BREAKAGE 51 0.0013
923 INTENTIONAL OVERDOSE 80 0.0012
924 TRANSIENT ISCHAEMIC ATTACK 42 0.0012
925 INTERSTITIAL LUNG DISEASE 60 0.0012
926 DRUG EFFECT INCOMPLETE 45 0.0012
927 RESPIRATORY FAILURE 90 0.0012
928 RESTLESSNESS 45 0.0012
929 DRUG DOSE OMISSION 203 0.0012
930 RED BLOOD CELL COUNT DECREASED 35 0.0012
931 THROMBOSIS 97 0.0012
932 PRODUCT STORAGE ERROR 104 0.0012
933 MOVEMENT DISORDER 38 0.0012
934 SEIZURE 136 0.0012
935 DRUG ADMINISTRATION ERROR 36 0.0012
936 NEUROPATHY PERIPHERAL 111 0.0012
937 OXYGEN SATURATION DECREASED 64 0.0011
938 INJECTION SITE BRUISING 90 0.0011
939 RENAL IMPAIRMENT 94 0.0011
940 CEREBRAL HAEMORRHAGE 40 0.0011
941 FEELING COLD 31 0.0011
942 DISORIENTATION 44 0.0011
943 ARRHYTHMIA 51 0.0011
944 INJECTION SITE REACTION 74 0.0011
945 MALIGNANT NEOPLASM PROGRESSION 110 0.0011
946 HEPATIC FAILURE 32 0.0011
947 CARDIAC FAILURE 85 0.0011
948 MYELOSUPPRESSION 38 0.0011
949 ASCITES 31 0.0011
950 CARDIAC DISORDER 95 0.0010
951 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 47 0.0010
952 ACUTE KIDNEY INJURY 152 0.0010
953 SPEECH DISORDER 52 0.0010
954 CORONARY ARTERY DISEASE 30 0.0010
955 WITHDRAWAL SYNDROME 41 0.0010
956 TREMOR 160 0.0010
957 ACCIDENTAL EXPOSURE TO PRODUCT 99 0.0010
958 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 49 0.0009
959 HOSPITALISATION 143 0.0009
960 ATRIAL FIBRILLATION 90 0.0009
961 NEOPLASM PROGRESSION 32 0.0009
962 INJECTION SITE HAEMORRHAGE 73 0.0009
963 HYPOTENSION 183 0.0009
964 CARDIAC FAILURE CONGESTIVE 70 0.0009
965 DEVICE EXPULSION 56 0.0009
966 ACCIDENTAL OVERDOSE 31 0.0008
967 INJECTION SITE PAIN 253 0.0008
968 DYSPNOEA EXERTIONAL 31 0.0008
969 BALANCE DISORDER 71 0.0008
970 PLATELET COUNT DECREASED 86 0.0008
971 LUNG NEOPLASM MALIGNANT 33 0.0008
972 BREAST CANCER 72 0.0008
973 MYOCARDIAL INFARCTION 132 0.0008
974 BRADYCARDIA 39 0.0007
975 CARDIAC ARREST 60 0.0007
976 MULTIPLE SCLEROSIS 34 0.0007
977 HYPONATRAEMIA 39 0.0007
978 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 135 0.0007
979 INJECTION SITE SWELLING 51 0.0007
980 DEATH 570 0.0007
981 BLOOD GLUCOSE INCREASED 124 0.0007
982 COMA 31 0.0007
983 INJECTION SITE PRURITUS 42 0.0006
984 INJECTION SITE ERYTHEMA 74 0.0006
985 DEVICE ISSUE 50 0.0006
986 TOXICITY TO VARIOUS AGENTS 74 0.0004
987 DYSGEUSIA 32 0.0004
988 DEVICE MALFUNCTION 30 0.0004
989 DRUG DEPENDENCE 42 0.0003